Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EBT (2016 - 2025)

Historic EBT for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $97.8 million.

  • Innoviva's EBT rose 132819.39% to $97.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.3 million, marking a year-over-year increase of 188310.99%. This contributed to the annual value of $37.4 million for FY2024, which is 8073.76% down from last year.
  • As of Q3 2025, Innoviva's EBT stood at $97.8 million, which was up 132819.39% from $72.6 million recorded in Q2 2025.
  • Innoviva's 5-year EBT high stood at $286.4 million for Q3 2022, and its period low was -$39.3 million during Q2 2024.
  • Over the past 5 years, Innoviva's median EBT value was $41.1 million (recorded in 2023), while the average stood at $51.8 million.
  • In the last 5 years, Innoviva's EBT crashed by 77664.08% in 2024 and then surged by 132819.39% in 2025.
  • Over the past 5 years, Innoviva's EBT (Quarter) stood at -$6.0 million in 2021, then tumbled by 70.77% to -$10.3 million in 2022, then skyrocketed by 36.31% to -$6.6 million in 2023, then plummeted by 60.22% to -$10.5 million in 2024, then skyrocketed by 1028.14% to $97.8 million in 2025.
  • Its EBT stands at $97.8 million for Q3 2025, versus $72.6 million for Q2 2025 and -$38.6 million for Q1 2025.